Joseph Newell's most recent trade in Atara Biotherapeutics Inc was a trade of 3,332 Common Stock done at an average price of $17.1 . Disclosure was reported to the exchange on Nov. 16, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 17.12 per share. | 16 Nov 2021 | 3,332 | 113,097 (0%) | 0% | 17.1 | 57,034 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 17.71 per share. | 15 Nov 2021 | 7,000 | 116,429 (0%) | 0% | 17.7 | 124,004 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.15 per share. | 15 Nov 2021 | 3,500 | 123,429 (0%) | 0% | 12.2 | 42,525 | Common Stock |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2021 | 2,792 | 32,083 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Joseph Newell | Chief Operations Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2021 | 708 | 9,917 | - | - | Employee Stock Option (Right to Buy) |